8-10 April 2025, Sir Charles Wilson Building, University of Glasgow, Glasgow, Scotland, UK
The drive for the new generation of vaccine therapies has precipitated a concurrent need for new and improved adjuvantation/delivery systems for these new vaccines. This regular series international conference will focus on updating the community on new adjuvant/delivery systems/technologies associated with developing modern vaccines strategies and vaccine research. Post the COVID pandemic there is now an urgent need for the development of these potent and safe adjuvants and delivery systems and MVADS 20259 will again offer researchers a fresh forum to discuss these important topics in detail. MVADS 2025 will be of interest to researchers/contributors from academic programs, industrial, governmental and regulatory groups.
Scientific Advisory Panel
Conference Chairman: James Brewer (University of Glasgow, Glasgow, Scotland, UK)
Dennis Christensen (CRODA Denmark, Frederikssund, Denmark)
Gabriel Pedersen (Statens Serum Institut, Copenhagen, Denmark)
Martin Bachmann (Inselspital, Bern, Switzerland / University of Oxford, Oxford, UK)
Jean Haensler (Sanofi, Marcy L’Etoile, France)
Derek O’Hagan (GSK Vaccine Research, Cambridge, Massachusetts, USA)
Stefan Jungbluth (European Vaccine Initiative (EVI), Heidelberg, Germany)
Ken Ishii (IMS/University of Tokyo, Tokyo, Japan)
Edward Lavelle (Trinity College Dublin, Dublin, Ireland)
Arnaud Didier-Laurent (University of Geneva, Geneva, Switzerland)
Sabine Wellnitz (Pfizer Inc., Pearl River, New York, USA)
Emanuele Montomoli (VisMederi Holdings/University of Siena, Siena, Italy)
Sean Tucker (VAXART Inc, South San Francisco, California, USA)
Patrick Syntin (Sanofi, Marcy L’Etoile, France)
Ali Harandi (University of Gothenburg, Gothenburg, Sweden)
Yvonne Perrie (University of Strathclyde, Glasgow, Scotland, UK)
Virgil Schijns (SwiftPharma BV, Gent, Belgium)
Mona Muhsen (Inselspital, Bern, Switzerland)
Anne Moore (University College Cork, Cork, Ireland)
Thomas Courant (Vaccine Formulation Institute, Epalinges, Switzerland)
Conference Scope
Scientific Sessions:
- Mechanistic Interpretations
- Delivery
- Formulation & Design
- Modern Vaccines & Adjuvants
- Safety
- Regulation
- Future Developments